Opsonic and nonopsonic interactions of C3 with Streptococcus pneumoniae

Microbial Drug Resistance

Volumn 5, Issue 2, 1999, Pages 85-89

  Hostetter, Margaret K ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL POLYSACCHARIDE; BACTERIAL PROTEIN; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C3B RECEPTOR; OPSONIN; THIOESTER;

ANTIBODY RESPONSE; CHEMICAL BOND; HOST RESISTANCE; HUMAN; NONHUMAN; OPSONIZATION; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REVIEW; STREPTOCOCCUS PNEUMONIAE;

EID: 0032800221     PISSN: 10766294     EISSN: None     Source Type: Journal    
DOI: 10.1089/mdr.1999.5.85     Document Type: Review

References (17)

1. Wright, A.E., and S.R. Douglas. 1903. An experimental investigation of blood fluids in connection with phagocytosis. Proc. R. Soc. Lond. B. Biol. Sci. 72:357-370.
2. Ward, H.K., and J.F. Enders. 1933. An analysis of the opsonic and tropic action of normal and immune sera based on experiments with the pneumococcus. J. Exp. Med. 57:527-547.
3. Smith, M.R., and W.B. Wood, Jr. 1969. Heat labile opsonins to pneumococcus. I. Participation of complement. J. Exp. Med. 129:1209-1225.
4. Johnston, R.B., M.R. Klemperer, C.A. Alper, and F.S. Rosen. 1969. The enhancement of bacterial phagocytosis by serum. J. Exp. Med. 129:1275-1290.
5. Alper, C.A., H.R. Colten, F.S. Rosen, A.R. Rabson, G.M. Mac-Nab, and J.S.S. Gear. 1972. Homozygous deficiency of C3 in a patient with repeated infections. Lancet 2:1179-1181.
6. Hosea, S.W., E.J. Brown, and M.M. Frank. 1980. The critical role of complement in experimental pneumococcal sepsis. J. Infect. Dis. 42:903-909.
7. Auerbach, H.S., R. Burger, A. Dodds, and H.R. Colten. 1990. Molecular basis of complement C3 deficiency in guinea pigs. J. Clin. Invest. 86:96-106.
8. Winkelstein, J.A., L.C. Cork, D.E. Griffin, R.J. Adams, and D.L. Price. 1981. Genetically determined efficiency of the third component of complement in the dog. Science. 212:1169-1173.
9. Tack, B.F., and J.W. Prahl. 1976. Third component of human complement: purification from plasma and physiochemical characterization. Biochemistry 15:4513-4521.
10. Tack, B.F., R.A. Harrison, J. Janatova, M.L. Thomas, and J.W. Prahl. 1980. Evidence for presence of an internal thiolester bond in third component of human complement. Proc. Natl. Acad. Sci. U.S.A. 77:5764-5768.
11. Tack, B.F. 1983. The b-CYS-g-GLU thiolester bond in human C3, C4, and a2-macroglobulin. Springer Sermin. Immunopathol. 6:259-282.
12. Hostetter, M.K., M.L. Thomas, F.S. Rosen, and B.F. Tack. 1982. Binding of C3b proceeds by a transesterification reaction at the thiolester site. Nature 298:72-75.
13. Capel, PJ.A., R.O. Groeneboe, G. Grosveld, and K.W. Pondman. 1978. The binding of activated C3 to polysaccharides and immunoglobulins. J. Immunol. 121:2566-2572.
14. Mann, J., R. O'Brien, M.K. Hostetter, C.A. Alper, S.R. Rosen, and B.M. Babior. 1981. The third component of complement: covalent attachment of a radioactive sugar to the labile binding site of C3 via the alternative pathway. J. Immunol. 236:2370-2372.
15. Winkelstein, J.A., and A. Tomasz. 1977. Activation of the alternative pathway by pneumococcal cell walls. J. Immunol. 118:451-454.
16. Winkelstein, J.A., and A. Tomasz. 1978. Activation of the alternative complement pathway by pneumococcal cell wall teichoic acid. J. Immunol. 120:174-178.
17. Winkelstein, J.A., A.S. Abramovitz, and A. Tomasz. 1980. Activation of C3 via the alternative complement pathway results in fixation of C3b to the pneumococcal cell wall. J. Immunol. 124:2502-2506.